Press Release
Psyched Wellness LTD. Adds Aaron Slater to the Advisory Board
Toronto, Ontario, December 8, 2020 – Psyched Wellness Ltd. (formerly Duncan Park Holdings Corporation) (CSE:PSYC, OTC Pink: DCNPF) (the “Company” or “Psyched”) a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that Aaron Slater has joined the advisory board of the Company to work with the team on exploring new markets for its products and identifying possible M&A opportunities.
“I have followed the development of Psyched Wellness for a considerable amount of time. The functional and psychedelic mushroom industry's role in enhancing the health and wellness of society is an important endeavor,” says Aaron Slater. “I was attracted to Psyched Wellness opportunity due to a well-developed business plan and related growth strategy. Jeff Stevens, executive management, and the Board of Directors form an experienced and talented team that will enhance shareholder value. I look forward to supporting them and the Company in realizing its tremendous potential.
Aaron Slater has over twenty-five years of experience in Corporate Finance, M&A and Merchant Banking. He has been involved in over US$8 billion in transactions including a number of buy-out deals in Latin America, USA and Canada following from which he continues to maintain his involvement through being a director or shareholder. Currently, Aaron is a shareholder and executive director of one of the largest organic farms in Latina America. Aaron has worked with various High Net Worth Individuals, Family Offices and Hedge Funds to provide them a private equity capability that includes deal sourcing, structuring, investment oversight and managing liquidity events. These efforts have resulted in numerous successful investments with a specific focus on agriculture, natural resources and sustainability.
Aaron was head of Corporate Finance in the Americas for Standard Bank Group focusing primarily in middle market companies. Prior to that he was with Royal Bank of Canada where he implemented and established a corporate finance and M&A product line for the private banking client base throughout the United States, Latin America and the Caribbean. Previous to that Aaron was part of NationsBanc Montgomery Securities Investment Banking Group.
Aaron holds a B.A. in Political Science from the University of Western Ontario and an M.A. in International Relations from the University of Miami.
“I am thrilled to add Aaron to our advisory board, he brings with him a wealth of knowledge and experience in M&A and deal structuring that we believe will be hugely beneficial to the company as we and the industry continues to grow,” said Jeff Stevens, CEO of the Company. “Having access to the Latin and South American markets provides us with a distinct edge, as so many natural psychedelic compounds have a long history of use and consumption in those markets.”
The Company has also issued 250,000 options at a strike price of $0.225 to certain advisors and consultants.
-30-
Neither the Canadian Securities Exchange nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release.
About Psyched Wellness Ltd.:
Psyched Wellness Ltd. is a Canadian-based health supplements company dedicated to the distribution of mushroom-derived products and associated consumer packaged goods. The Company’s objective is to create premium mushroom-derived products that have the potential to become a leading North American brand in the emerging functional food category. The Company is in the process of developing a line of Amanita muscaria-derived water-based extracts, teas and capsules designed to help with three health objectives: promote stress relief, relaxation and assist with restful sleeping.
Cautionary Statement Regarding Forward Looking Information
This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company’s current belief or assumptions as to the outcome and timing of such future events. The forward-looking information and forward- looking statements contained herein include, but are not limited to, statements regarding: the ability of the Company to develop Amanita Muscaria-derived products; the safety of Amanita Muscaria consumption and the safety and purity of any extracts thereof; and (ii) the uses and potential benefits of Amanita Muscaria.
Forward-looking information in this news release are based on certain assumptions and expected future events, namely: the Company’s ability to continue as a going concern; the Company’s ability to continue to develop its mushroom-derived products and associated consumer packaged goods; continued approval of the Company’s activities by the relevant governmental and/or regulatory authorities; and the continued growth of the Company.
These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including but not limited to: the potential inability of the Company to continue as a going concern; risks associated with potential governmental and/or regulatory action with respect to the Company’s operations; competition within the psychedelics market; risks with respect to the safety of Amanita Muscaria consumption and the safety and purity of any extracts thereof; and the risk that there is no potential benefit of Amanita Muscaria consumption.
Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.
Forward-looking statements contained in this news release are expressly qualified by this cautionary statement and reflect the Company’s expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.
For further information, please contact:
Jeffrey Stevens
Chief Executive Officer
Psyched Wellness Ltd.
t: (647) 400-8494
e: jstevens@psyched-wellness.com
Website: http://www.psyched-wellness.com
Investor Contacts:
Tim Regan/Sophia Bashford
KCSA Strategic Communications
t: (978) 505-2478
e: PsychedWellness@kcsa.com